Burden of Disease Matters When It Comes to Systemic Therapy for Prostate Cancer

被引：2
|
作者：
Harrison, Michael R. [1 ]
Armstrong, Andrew J. [1 ,2 ]
机构：
[1] Duke Univ, Med Ctr, Duke Canc Inst, Dept Med, Durham, NC USA
[2] Duke Univ, Med Ctr, Duke Canc Inst, Dept Surg, Durham, NC USA
来源：
EUROPEAN UROLOGY | 2015年 / 67卷 / 03期
关键词：
PROGNOSTIC MODEL; SURVIVAL; CASTRATION; MEN; CHEMOTHERAPY; NOMOGRAM;
D O I：
10.1016/j.eururo.2014.02.032
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：448 / 450
页数：3
相关论文
共 50 条
  • [21] Systemic therapy of prostate cancer in elderly patients
    von Amsberg, Gunhild
    Busenbender, Tobias
    Tilki, Derya
    Bokemeyer, Carsten
    ONKOLOGIE, 2024, 30 (02): : 119 - 128
  • [22] Focal therapy for prostate cancer - when to refer?
    Rokan, Nadia
    Reddy, Deepika
    Dudderidge, Tim
    BJU INTERNATIONAL, 2024, 133 (06) : 665 - 666
  • [23] Optimal Taxation When the Tax Burden Matters
    Jessen, Robin
    Metzing, Maria
    Rostam-Afschar, Davud
    FINANZARCHIV-EUROPEAN JOURNAL OF PUBLIC FINANCE, 2022, 78 (03): : 312 - 341
  • [24] Prostate cancer matters
    Sandler, Howard M.
    SEMINARS IN RADIATION ONCOLOGY, 2008, 18 (01) : 1 - 1
  • [25] High-Risk Prostate Cancer: Local Therapy Matters
    Liss, Adam L.
    Hamstra, Daniel A.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (06) : 14 - 19
  • [26] IS THERE SUCH THING AS FAT AND FIT WHEN IT COMES TO PROSTATE CANCER RISK? INTERPLAY BETWEEN BMI, EXERCISE, AND PROSTATE CANCER RISK
    Michael, Jamie
    Oyekunle, Taofik
    Howard, Lauren
    DeHoedt, Amanda
    Bailey, Charlotte
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2018, 199 (04): : E263 - E264
  • [27] Money matters and so does autonomy when it comes to health
    Covan, Eleanor Krassen
    HEALTH CARE FOR WOMEN INTERNATIONAL, 2017, 38 (01) : 1 - 1
  • [28] When it comes to ocean extinctions, range size matters most
    不详
    MARINE POLLUTION BULLETIN, 2012, 64 (12) : 2618 - 2618
  • [29] What matters most when it comes to vocabulary and language development?
    Lous, Jorgen
    ACTA PAEDIATRICA, 2019, 108 (02) : 202 - 203
  • [30] Is there an indication for adjuvant or neoadjuvant systemic therapy in prostate cancer?
    Boergermann, C.
    Miller, K.
    vom Dorp, F.
    Jaeger, T.
    Ruebben, H.
    UROLOGE, 2007, 46 (10): : 1385 - +
12345